[1] |
Zhao SG,Mugabo Y,Ballentine G,et al.alpha/beta-Hydrolase domain 6 deletion Induces adipose browning and prevents obesity and type 2 diabetes[J].Cell Rep, 2016,14(12):2872-2888.
|
[2] |
Wang XN,Xu B,Zhou JP,et al.Advances of anti-diabetic drugs based on new targets[J].J China Pharm Univ(中国药科大学学报),2015,46(2): 141-152.
|
[3] |
Wei QQ,Zhou JP,Zhang HB,et al.Recent research progress in small molecule AMPK direct activators[J].J China Pharm Univ(中国药科大学学报),2015,46(4): 406-415.
|
[4] |
Thomas G,Betters JL,Lord CC,et al.The serine hydrolase ABHD6 is a critical regulator of the metabolic syndrome[J].Cell Rep, 2013,5(2):508-520.
|
[5] |
Lord CC,Thomas G,Brown JM.Mammalian(ABHD)proteins: lipid metabolizing enzymes at the interface of cell signaling and energy metabolism[J].Biochim Biophys Acta, 2013,1831(4):792-802.
|
[6] |
Marco N,Bauke WD.α/β Hydrolase fold enzymes: the family keeps growing[J].Curr Opin Struct Biol, 1999, 9:732-737.
|
[7] |
Thomas G,Brown AL,Brown JM.In vivo metabolite profiling as a means to identify uncharacterized lipase function: recent success stories within the alpha beta hydrolase domain(ABHD)enzyme family[J].Biochim Biophys Acta, 2014,1841(8):1097-1101.
|
[8] |
Dina NP,Savinainen JR,Jarmo TL.Biochemical and pharmacological characterization of human alpha/beta-hydrolase domain containing 6(ABHD6)and 12(ABHD12)[J].J Lipid Res, 2012,53(11):2413-2424.
|
[9] |
Prentki M,Matschinsky FM,Madiraju SR.Metabolic signaling in fuel-induced insulin secretion[J].Cell Metab, 2013,18(2):162-185.
|
[10] |
Labar G,Wouters J,Lambert DM.A review on the monoacylglycerol lipase: at the interface between fat and endocannabinoid signalling [J].Curr Med Chem, 2010, 17: 2588-2607.
|
[11] |
Kang L,He Z,Xu P,et al.Munc13-1 is required for the sustained release of insulin from pancreatic beta cells[J].Cell Metab,2006,3(6):463-468.
|
[12] |
Prentki M, Madiraju SR. Glycerolipid/free fatty acid cycle and islet beta-cell function in health,obesity and diabetes[J].Mol Cell Endocrinol, 2012,353(1/2):88-100.
|
[13] |
Henquin JC. The dual control of insulin secretion by glucose involves triggering and amplifying pathways in β-cells[J].Diabetes Res Clin Pract, 2011,93:S27-S31.
|
[14] |
Wen J,Ribeiro R,Tanaka M,et al.Activation of CB2 receptor is required for the therapeutic effect of ABHD6 inhibition in experimental autoimmune encephalomyelitis[J].Neuropharmacology,2015,99:196-209.
|
[15] |
Ueda N,Tsuboi K.Discrimination between two endocannabinoids[J].Chem Biol, 2012,19(5):545-547.
|
[16] |
Hu J,Zhu C,Huang M.The endocannabinoid system: a new pharmacological target for obesity treatment [J] ? Neurosci Bull,2009,25(3):153-160.
|
[17] |
Alhouayek M,Masquelier J,Muccioli GG.Controlling 2-arachidonoylglycerol metabolism as an anti-inflammatory strategy[J].Drug Discov Today,2014,19(3):295-304.
|
[18] |
Mulvihill MM,Nomura DK.Therapeutic potential of monoacylglycerol lipase inhibitors[J].Life Sci,2013,92(8/9):492-497.
|
[19] |
Townsend KL,Tseng YH.Brown fat fuel utilization and thermogenesis[J].Trends Endocrinol Metab,2014,25(4):168-177.
|
[20] |
Derosa G,Cicero AF,Angelo DA,et al.Effects of 1-year orlistat treatment compared to placebo on insulin resistance parameters in patients with type 2 diabetes[J].J Clin Pharm Ther,2012,37(2):187-195.
|
[21] |
Marrs WR,Horne EA,Ortega GS,et al.Dual inhibition of alpha/beta-hydrolase domain 6 and fatty acid amide hydrolase increases endocannabinoid levels in neurons[J].J Biol Chem,2011, 286(33):28723-28728.
|
[22] |
Blankman JL,Simon GM,Cravatt BF.A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol[J].Chem Biol,2007,14(12):1347-1356.
|
[23] |
Chang JW,Cognetta AB,Niphakis MJ,et al.Proteome-wide reactivity profiling identifies diverse carbamate chemotypes tuned for serine hydrolase inhibition[J].ACS Chem Biol,2013,8(7):1590-1599.
|
[24] |
Bowman AL,Makriyannis A.Highly predictive ligand-based pharmacophore and homology models of ABHD6[J].Chem Biol Drug Des,2013,81(3):382-388.
|
[25] |
Tchantchou F,Zhang YM.Selective inhibition of alpha/beta-hydrolase domain 6 attenuates neurodegeneration,alleviates blood brain barrier breakdown,and improves functional recovery in a mouse model of traumatic brain injury[J].J Neurotrauma,2013,30(7):565-579.
|
[26] |
Christian P,Sacco J,Adeli K.Autophagy: emerging roles in lipid homeostasis and metabolic control[J].Biochim Biophys Acta,2013,1831(4):819-824.
|
[27] |
Hsu KL,Tsuboi K,Whitby LR,et al.Development and optimization of piperidyl 1,2,3-triazole ureas as selective chemical probes of endocannabinoid biosynthesis[J].J Med Chem,2013,56(21):8257-8269.
|
[28] |
Hsu KL,Tsuboi K,Adibekian A,et al.DAGLbeta inhibition perturbs a lipid network involved in macrophage inflammatory responses[J].Nat Chem Biol,2012,8(12):999-1007.
|
[29] |
Patel JZ,Nevalainen TJ,Savinainen JR,et al.Optimization of 1,2,5-thiadiazole carbamates as potent and selective ABHD6 inhibitors[J].ChemMedChem,2015,10(2):253-265.
|
[30] |
Patel JZ,Bruchem JV,Laitinen T,et al.Revisiting 1,3,4-oxadiazol-2-ones: utilization in the development of ABHD6 inhibitors[J].Bioorg Med Chem,2015,23(19):6335-6345.
|
[31] |
Janssen FJ,Deng H,Baggelaar MP,et al.Discovery of glycine sulfonamides as dual inhibitors of sn-1-diacylglycerol lipase alpha and alpha/beta-hydrolase domain 6[J].J Med Chem,2014,57(15):6610-6622.
|
[32] |
Murthy MS,Marc P,Erik J,et al.ABHD6 antagonists for promoting browning of white adipose tissue functionality: WO,2015127559A1[P].2015-09-03[2016-12-30] .
|
[33] |
Cisar JS,Grice CA,Jones TK,et al.Carbamate compounds and of making and using same:US,20150018335A1[P].2015-01-15[2016-12-30] .
|
[34] |
Pribasnig MA,Mrak I,Grabner GF,et al.alpha/beta Hydrolase domain-containing 6(ABHD6)degrades the late endosomal/lysosomal lipid bis(monoacylglycero)- phosphate[J].J Biol Chem,2015,290(50):29869-29881.
|
[35] |
Zhao SG,Poursharifi P,Mugabo Y,et al.alpha/beta-Hydrolase domain-6 and saturated long chain monoacylglycerol regulate insulin secretion promoted by both fuel and non-fuel stimuli[J].Mol Metab,2015,4(12):940-950.
|